116 related articles for article (PubMed ID: 23411075)
1. Arylglycine derivatives as potent transient receptor potential melastatin 8 (TRPM8) antagonists.
Zhu B; Xia M; Xu X; Ludovici DW; Tennakoon M; Youngman MA; Matthews JM; Dax SL; Colburn RW; Qin N; Hutchinson TL; Lubin ML; Brandt MR; Stone DJ; Flores CM; Macielag MJ
Bioorg Med Chem Lett; 2013 Apr; 23(7):2234-7. PubMed ID: 23411075
[TBL] [Abstract][Full Text] [Related]
2. Fused piperidines as a novel class of potent and orally available transient receptor potential melastatin type 8 (TRPM8) antagonists.
Tamayo NA; Bo Y; Gore V; Ma V; Nishimura N; Tang P; Deng H; Klionsky L; Lehto SG; Wang W; Youngblood B; Chen J; Correll TL; Bartberger MD; Gavva NR; Norman MH
J Med Chem; 2012 Feb; 55(4):1593-611. PubMed ID: 22329507
[TBL] [Abstract][Full Text] [Related]
3. The design and synthesis of novel, phosphonate-containing transient receptor potential melastatin 8 (TRPM8) antagonists.
Matthews JM; Qin N; Colburn RW; Dax SL; Hawkins M; McNally JJ; Reany L; Youngman MA; Baker J; Hutchinson T; Liu Y; Lubin ML; Neeper M; Brandt MR; Stone DJ; Flores CM
Bioorg Med Chem Lett; 2012 Apr; 22(8):2922-6. PubMed ID: 22421018
[TBL] [Abstract][Full Text] [Related]
4. Optimization of potency and pharmacokinetic properties of tetrahydroisoquinoline transient receptor potential melastatin 8 (TRPM8) antagonists.
Horne DB; Tamayo NA; Bartberger MD; Bo Y; Clarine J; Davis CD; Gore VK; Kaller MR; Lehto SG; Ma VV; Nishimura N; Nguyen TT; Tang P; Wang W; Youngblood BD; Zhang M; Gavva NR; Monenschein H; Norman MH
J Med Chem; 2014 Apr; 57(7):2989-3004. PubMed ID: 24597733
[TBL] [Abstract][Full Text] [Related]
5. Design and optimization of benzimidazole-containing transient receptor potential melastatin 8 (TRPM8) antagonists.
Parks DJ; Parsons WH; Colburn RW; Meegalla SK; Ballentine SK; Illig CR; Qin N; Liu Y; Hutchinson TL; Lubin ML; Stone DJ; Baker JF; Schneider CR; Ma J; Damiano BP; Flores CM; Player MR
J Med Chem; 2011 Jan; 54(1):233-47. PubMed ID: 21128593
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and optimization of novel α-phenylglycinamides as selective TRPM8 antagonists.
Kobayashi JI; Hirasawa H; Ozawa T; Ozawa T; Takeda H; Fujimori Y; Nakanishi O; Kamada N; Ikeda T
Bioorg Med Chem; 2017 Jan; 25(2):727-742. PubMed ID: 27964995
[TBL] [Abstract][Full Text] [Related]
7. (-)-Menthylamine derivatives as potent and selective antagonists of transient receptor potential melastatin type-8 (TRPM8) channels.
Ortar G; De Petrocellis L; Morera L; Moriello AS; Orlando P; Morera E; Nalli M; Di Marzo V
Bioorg Med Chem Lett; 2010 May; 20(9):2729-32. PubMed ID: 20378345
[TBL] [Abstract][Full Text] [Related]
8. Isoxazole derivatives as potent transient receptor potential melastatin type 8 (TRPM8) agonists.
Ostacolo C; Ambrosino P; Russo R; Lo Monte M; Soldovieri MV; Laneri S; Sacchi A; Vistoli G; Taglialatela M; Calignano A
Eur J Med Chem; 2013 Nov; 69():659-69. PubMed ID: 24095758
[TBL] [Abstract][Full Text] [Related]
9. Structure-activity relationships of the prototypical TRPM8 agonist icilin.
De Petrocellis L; Ortar G; Schiano Moriello A; Serum EM; Rusterholz DB
Bioorg Med Chem Lett; 2015 Jun; 25(11):2285-90. PubMed ID: 25935641
[TBL] [Abstract][Full Text] [Related]
10. Menthol derivative WS-12 selectively activates transient receptor potential melastatin-8 (TRPM8) ion channels.
Ma S; G G; Ak VE; Jf D; H H
Pak J Pharm Sci; 2008 Oct; 21(4):370-8. PubMed ID: 18930858
[TBL] [Abstract][Full Text] [Related]
11. Identification of N-acyl-N-indanyl-α-phenylglycinamides as selective TRPM8 antagonists designed to mitigate the risk of adverse effects.
Kobayashi JI; Hirasawa H; Fujimori Y; Nakanishi O; Kamada N; Ikeda T; Yamamoto A; Kanbe H
Bioorg Med Chem; 2021 Jan; 30():115903. PubMed ID: 33333445
[TBL] [Abstract][Full Text] [Related]
12. Differential behavioral effect of the TRPM8/TRPA1 channel agonist icilin (AG-3-5).
Rawls SM; Gomez T; Ding Z; Raffa RB
Eur J Pharmacol; 2007 Dec; 575(1-3):103-4. PubMed ID: 17765220
[TBL] [Abstract][Full Text] [Related]
13. Tryptamine-Based Derivatives as Transient Receptor Potential Melastatin Type 8 (TRPM8) Channel Modulators.
Bertamino A; Ostacolo C; Ambrosino P; Musella S; Di Sarno V; Ciaglia T; Soldovieri MV; Iraci N; Fernandez Carvajal A; de la Torre-Martinez R; Ferrer-Montiel A; Gonzalez Muniz R; Novellino E; Taglialatela M; Campiglia P; Gomez-Monterrey I
J Med Chem; 2016 Mar; 59(5):2179-91. PubMed ID: 26847872
[TBL] [Abstract][Full Text] [Related]
14. Identification of a novel 2-pyridyl-benzensulfonamide derivative, RQ-00203078, as a selective and orally active TRPM8 antagonist.
Ohmi M; Shishido Y; Inoue T; Ando K; Fujiuchi A; Yamada A; Watanabe S; Kawamura K
Bioorg Med Chem Lett; 2014 Dec; 24(23):5364-8. PubMed ID: 25455182
[TBL] [Abstract][Full Text] [Related]
15. Characterization of functional transient receptor potential melastatin 8 channels in human pancreatic ductal adenocarcinoma cells.
Cucu D; Chiritoiu G; Petrescu S; Babes A; Stanica L; Duda DG; Horii A; Dima SO; Popescu I
Pancreas; 2014 Jul; 43(5):795-800. PubMed ID: 24658318
[TBL] [Abstract][Full Text] [Related]
16. Discovery of vinylcycloalkyl-substituted benzimidazole TRPM8 antagonists effective in the treatment of cold allodynia.
Calvo RR; Meegalla SK; Parks DJ; Parsons WH; Ballentine SK; Lubin ML; Schneider C; Colburn RW; Flores CM; Player MR
Bioorg Med Chem Lett; 2012 Mar; 22(5):1903-7. PubMed ID: 22330635
[TBL] [Abstract][Full Text] [Related]
17. Characterisation of TRPM8 as a pharmacophore receptor.
Bödding M; Wissenbach U; Flockerzi V
Cell Calcium; 2007 Dec; 42(6):618-28. PubMed ID: 17517434
[TBL] [Abstract][Full Text] [Related]
18. Transient receptor potential channel TRPM8 agonists stimulate calcium influx and neurotensin secretion in neuroendocrine tumor cells.
Mergler S; Strowski MZ; Kaiser S; Plath T; Giesecke Y; Neumann M; Hosokawa H; Kobayashi S; Langrehr J; Neuhaus P; Plöckinger U; Wiedenmann B; Grötzinger C
Neuroendocrinology; 2007; 85(2):81-92. PubMed ID: 17426390
[TBL] [Abstract][Full Text] [Related]
19. Novel selective, potent naphthyl TRPM8 antagonists identified through a combined ligand- and structure-based virtual screening approach.
Beccari AR; Gemei M; Lo Monte M; Menegatti N; Fanton M; Pedretti A; Bovolenta S; Nucci C; Molteni A; Rossignoli A; Brandolini L; Taddei A; Za L; Liberati C; Vistoli G
Sci Rep; 2017 Sep; 7(1):10999. PubMed ID: 28887460
[TBL] [Abstract][Full Text] [Related]
20. Icilin evokes a dose- and time-dependent increase in glutamate within the dorsal striatum of rats.
Werkheiser JL; Rawls SM; Cowan A
Amino Acids; 2006 May; 30(3):307-9. PubMed ID: 16622598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
